NO20050044L - Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom - Google Patents

Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom

Info

Publication number
NO20050044L
NO20050044L NO20050044A NO20050044A NO20050044L NO 20050044 L NO20050044 L NO 20050044L NO 20050044 A NO20050044 A NO 20050044A NO 20050044 A NO20050044 A NO 20050044A NO 20050044 L NO20050044 L NO 20050044L
Authority
NO
Norway
Prior art keywords
chrohn
disease
preparation
treatment
colitis ulcerosa
Prior art date
Application number
NO20050044A
Other languages
English (en)
Other versions
NO20050044D0 (no
Inventor
Gunnar Nysaeter
Arnold Berstad
Original Assignee
Innovest As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovest As filed Critical Innovest As
Priority to NO20050044A priority Critical patent/NO20050044L/no
Publication of NO20050044D0 publication Critical patent/NO20050044D0/no
Priority to PCT/NO2006/000002 priority patent/WO2006073311A2/en
Publication of NO20050044L publication Critical patent/NO20050044L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20050044A 2005-01-04 2005-01-04 Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom NO20050044L (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO20050044A NO20050044L (no) 2005-01-04 2005-01-04 Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom
PCT/NO2006/000002 WO2006073311A2 (en) 2005-01-04 2006-01-04 Treatment of ibd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20050044A NO20050044L (no) 2005-01-04 2005-01-04 Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom

Publications (2)

Publication Number Publication Date
NO20050044D0 NO20050044D0 (no) 2005-01-04
NO20050044L true NO20050044L (no) 2006-07-05

Family

ID=35209736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050044A NO20050044L (no) 2005-01-04 2005-01-04 Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom

Country Status (2)

Country Link
NO (1) NO20050044L (no)
WO (1) WO2006073311A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022117823A1 (en) * 2020-12-04 2022-06-09 Valneva Se Methods and compositions for preventing and/or treating autoimmune diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107305D0 (en) * 1991-04-08 1991-05-22 Unilever Plc Probiotic
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
WO2005058355A1 (en) * 2003-12-11 2005-06-30 Creatogen Laboratories Gmbh Immune stimulation by administration of bacteria

Also Published As

Publication number Publication date
WO2006073311A2 (en) 2006-07-13
NO20050044D0 (no) 2005-01-04
WO2006073311A3 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
CY2015024I2 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
EP1951892A4 (en) ANTIBODY TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
DK1847524T3 (da) Terphenylderivater til behandling af Alzheimers sygdom
EP2268647A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE IDENTIFICATION AND TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
DK1962869T3 (da) Behandling af luftvejssygdomme
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
HU0500145D0 (en) Composition for the treatment of oral diseases
IL188318A0 (en) Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
NO20050044L (no) Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
GB0425054D0 (en) Formamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
ERR Erratum

Free format text: BLE NY PATENTSOKNAD NR.20050044 KUNNGJORT MED FEIL LOPEDAG. RIKTIG LOPEDAG ER 20050104. FOR OVRIG HAR SOKNADEN FATT NORSK BENEVNELSE:"PREPARAT FOR BEHANDLING AV COLITIS ULCEROSA & CHROHN S SYKDOM"